Literature DB >> 23861048

Image guided core needle biopsy of musculoskeletal lesions: are nondiagnostic results clinically useful?

Manjiri M Didolkar1, Megan E Anderson, Mary G Hochman, Julia G Rissmiller, Jeffrey D Goldsmith, Mark G Gebhardt, Jim S Wu.   

Abstract

BACKGROUND: The clinical utility of nondiagnostic core needle biopsies is not fully understood. Understanding the clinical and radiologic factors associated with nondiagnostic core needle biopsies may help determine the utility of these nondiagnostic biopsies and guide clinical decision making. QUESTIONS/PURPOSES: We asked (1) whether benign or malignant bone and soft tissue lesions have a higher rate of nondiagnostic core needle biopsy results, and which diagnoses have the lowest diagnostic yield; (2) how often nondiagnostic results affected clinical decision-making; and (3) what clinical factors are associated with nondiagnostic but useful core needle biopsies.
METHODS: A retrospective study was performed of 778 consecutive image-guided core needle biopsies of bone and soft tissue lesions referred to the musculoskeletal radiology department at a single institution. The reference standard was (1) the final diagnosis at surgery or (2) clinical followup. Diagnostic yield was calculated for the most common diagnoses. Clinical and imaging features related to each nondiagnostic core needle biopsy were assessed for their association with clinical usefulness. Useful nondiagnostic biopsies were defined as those that help guide treatment. Each lesion was assessed before biopsy by the orthopaedic oncologist as (1) "likely to be benign" or (2) "suspicious for malignancy." The overall diagnostic yield was 74%.
RESULTS: Malignant lesions had higher diagnostic yield than benign lesions: 94% (323 of 345) versus 58% (252 of 433), yielding a relative risk (RR) of 1.61 and 95% CI of 1.48 to 1.75. Soft tissue lesions had a higher diagnostic yield than bone lesions: 82% (291 of 355) versus 67% (284 of 423); RR, 1.22; 95% CI, 1.22 (1.12-1.33). Ganglion cyst (36%, four of 11), myositis ossificans (40%, two of five), Langerhans cell histiocytosis (0%, 0 of four), and simple bone cyst 0%, 0 of six) had the lowest diagnostic yield. Of the nondiagnostic biopsies assessed for clinical usefulness by the orthopaedic oncologist, 60% (85 of 142) of the biopsies were useful in guiding clinical decision making. Useful nondiagnostic core needle biopsy results occurred more often in painless, nonaggressive lesions, assessed as "likely to be benign" before biopsy.
CONCLUSIONS: Nondiagnostic core needle biopsy results in musculoskeletal lesions are not entirely useless. At times, they can be supportive of benign processes and can help avert unnecessary surgical procedures.

Entities:  

Mesh:

Year:  2013        PMID: 23861048      PMCID: PMC3792259          DOI: 10.1007/s11999-013-3170-9

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  26 in total

1.  CT-guided percutaneous core needle biopsy in deep seated musculoskeletal lesions: a prospective study of 128 cases.

Authors:  A Puri; V U Shingade; M G Agarwal; C Anchan; S Juvekar; S Desai; N A Jambhekar
Journal:  Skeletal Radiol       Date:  2005-12-09       Impact factor: 2.199

2.  Percutaneous CT-guided biopsy of osseous lesion of the spine in patients with known or suspected malignancy.

Authors:  Eric Lis; Mark H Bilsky; Leszek Pisinski; Patrick Boland; John H Healey; Bernie O'malley; George Krol
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

Review 3.  Percutaneous biopsy of skeletal lesions.

Authors:  S V Kattapuram; D I Rosenthal
Journal:  AJR Am J Roentgenol       Date:  1991-11       Impact factor: 3.959

4.  Diagnosis of primary bone tumors with image-guided percutaneous biopsy: experience with 110 tumors.

Authors:  James S Jelinek; Mark D Murphey; James A Welker; Robert M Henshaw; Mark J Kransdorf; Barry M Shmookler; Martin M Malawer
Journal:  Radiology       Date:  2002-06       Impact factor: 11.105

5.  Accuracy of computed tomography guided core needle biopsy of musculoskeletal tumours.

Authors:  Altay O Altuntas; John Slavin; Peter J Smith; Stephen M Schlict; Gerard J Powell; Sam Ngan; Guy Toner; Peter F M Choong
Journal:  ANZ J Surg       Date:  2005-04       Impact factor: 1.872

6.  Accurate diagnosis of musculoskeletal lesions by core needle biopsy.

Authors:  Goro Mitsuyoshi; Noriko Naito; Akira Kawai; Toshiyuki Kunisada; Aki Yoshida; Hiyoruki Yanai; Shuichi Dendo; Tadashi Yoshino; Susumu Kanazawa; Toshifumi Ozaki
Journal:  J Surg Oncol       Date:  2006-07-01       Impact factor: 3.454

7.  Accuracy of CT-guided needle biopsy of musculoskeletal neoplasms.

Authors:  D E Dupuy; A E Rosenberg; T Punyaratabandhu; M H Tan; H J Mankin
Journal:  AJR Am J Roentgenol       Date:  1998-09       Impact factor: 3.959

8.  Percutaneous needle biopsy of musculoskeletal lesions. 1. Effective accuracy and diagnostic utility.

Authors:  M A Fraser-Hill; D L Renfrew
Journal:  AJR Am J Roentgenol       Date:  1992-04       Impact factor: 3.959

9.  Diagnostic accuracy and charge-savings of outpatient core needle biopsy compared with open biopsy of musculoskeletal tumors.

Authors:  M C Skrzynski; J S Biermann; A Montag; M A Simon
Journal:  J Bone Joint Surg Am       Date:  1996-05       Impact factor: 5.284

10.  Accuracy of CT-guided biopsies in 359 patients with musculoskeletal lesions.

Authors:  Anwar Hau; Il Kim; Susan Kattapuram; Francis J Hornicek; Andrew E Rosenberg; Mark C Gebhardt; Henry J Mankin
Journal:  Skeletal Radiol       Date:  2002-03-07       Impact factor: 2.199

View more
  10 in total

1.  Percutaneous image-guided needle biopsy of clavicle lesions: a retrospective study of diagnostic yield with description of safe biopsy routes in 55 cases.

Authors:  I Pressney; A Saifuddin
Journal:  Skeletal Radiol       Date:  2014-10-21       Impact factor: 2.199

2.  Reduction of Radiation Dose and Scanning Time While Preserving Diagnostic Yield: A Comparison of Battery-Powered and Manual Bone Biopsy Systems.

Authors:  S Kihira; C Koo; A Lee; A Aggarwal; P Pawha; A Doshi
Journal:  AJNR Am J Neuroradiol       Date:  2020-02-06       Impact factor: 3.825

3.  CORR Insights®: Is Core Needle Biopsy Reliable in Differentiating Between Aggressive Benign and Malignant Radiolucent Bone Tumors?

Authors:  Jim S Wu
Journal:  Clin Orthop Relat Res       Date:  2018-03       Impact factor: 4.176

4.  CT-guided percutaneous biopsy of sclerotic bone lesions: diagnostic outcomes.

Authors:  I-Yuan Joseph Chang; Hakan Ilaslan; Murali Sundaram; Jean Schils; Naveen Subhas
Journal:  Skeletal Radiol       Date:  2017-12-07       Impact factor: 2.199

5.  Tenosynovial Giant Cell Tumor Mimicking Acute Septic Arthritis of the Hip: A Case Report.

Authors:  Evan Honig; Andrew Harris; Samir Sabharwal; Adam Levin; Erin Honcharuk
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2022-06-06

6.  Percutaneous CT-guided needle biopsies of musculoskeletal tumors: a 5-year analysis of non-diagnostic biopsies.

Authors:  Connie Y Chang; Ambrose J Huang; Miriam A Bredella; Martin Torriani; Elkan F Halpern; Daniel I Rosenthal; Dempsey S Springfield
Journal:  Skeletal Radiol       Date:  2015-09-04       Impact factor: 2.199

7.  Clinical application of a modified percutaneous vertebroplasty instrument in vertebral body biopsy in adults.

Authors:  Fubiao Zhou; Ningkui Niu; Qiang Liang; Yueliang Chang; Jiandang Shi; Zili Wang
Journal:  BMC Musculoskelet Disord       Date:  2022-02-19       Impact factor: 2.362

8.  Biopsy Ratio of Suspected to Confirmed Sarcoma Diagnosis.

Authors:  Nasian Mosku; Philip Heesen; Gabriela Studer; Beata Bode; Vito Spataro; Natalie D Klass; Lars Kern; Mario F Scaglioni; Bruno Fuchs
Journal:  Cancers (Basel)       Date:  2022-03-23       Impact factor: 6.639

9.  A Multidisciplinary Team Approach Is Highly Effective in the Management of Nondiagnostic Bone Tumour Biopsies: A 10-Year Retrospective Review at a Specialist Sarcoma Unit.

Authors:  Khabab Osman; Shakir Hussain; Frederick Downes; Vaiyapuri Sumathi; Rajesh Botchu; Scott Evans
Journal:  Sarcoma       Date:  2022-03-28

10.  Research on imbalance machine learning methods for MR[Formula: see text]WI soft tissue sarcoma data.

Authors:  Xuanxuan Liu; Li Guo; Hexiang Wang; Jia Guo; Shifeng Yang; Lisha Duan
Journal:  BMC Med Imaging       Date:  2022-08-26       Impact factor: 2.795

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.